The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor
1998

Effects of 4-Hydroxytamoxifen on Breast Cancer Cells

publication Evidence: moderate

Author Information

Author(s): AS Levenson, DA Tonetti, VC Jordan

Primary Institution: Robert H Lurie Cancer Centre, Northwestern University Medical School

Hypothesis

How does 4-hydroxytamoxifen regulate TGF-alpha gene expression in breast cancer cells?

Conclusion

4-hydroxytamoxifen shows estrogen-like effects on TGF-alpha gene expression in breast cancer cells.

Supporting Evidence

  • 4-hydroxytamoxifen increased TGF-alpha mRNA levels in a concentration-dependent manner.
  • Both estrogen and 4-hydroxytamoxifen activated the same gene in breast cancer cells.
  • The study used stable transfectants to analyze gene expression.

Takeaway

This study found that a drug called 4-hydroxytamoxifen can act like estrogen and help certain breast cancer cells produce a growth factor.

Methodology

The study involved stable transfectants of breast cancer cells and analyzed TGF-alpha mRNA levels using Northern blot and RT-PCR techniques.

Limitations

The study did not explore the long-term effects of 4-hydroxytamoxifen or the potential for resistance in breast cancer cells.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication